Please login to the form below

Not currently logged in
Email:
Password:

ISPE looks to Boehringer for new VP of Europe

Thomas Zimmer was senior VP at German pharma company
ispe thomas zimmer

Thomas Zimmer has left his senior VP role at Boehringer Ingelheim to join the International Society for Pharmaceutical Engineering (ISPE) as VP of European operations.

In his new role, Zimmer will be responsible for leading ISPE's business development and advancing strategic relationships in Europe.

He spent 32 years at German pharma company Boehringer, serving in senior roles across development, production, quality and supply chain management

In addition, Zimmer has experience at the European Federations of Pharmaceutical Industry Associations (EFPIA) and as a member of the World Health Organization's (WHO) IMPACT taskforce.

"Thomas joins ISPE with a strong foundation of pharmaceutical industry knowledge and relationships both within the Society and in the European professional community at large," said ISPE President and CEO Nancy Berg.

"Thomas's first-hand knowledge of the European regulatory environment and industry processes will be an important asset to ISPE as it continues to build best-in-class knowledge transfer offerings that are tailored to the needs of the pharmaceutical and biopharmaceutical industries both in Europe and around the world."

14th November 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics